Farnesyl thiotriazole, a potent neutrophil agonist and structurally novel activator of protein kinase C

Bryant A. Gilbert, Young Hee Lim, Jiabing Ding, John A. Badwey, Robert R. Rando

Research output: Contribution to journalArticle

15 Citations (Scopus)

Abstract

Farnesylcysteine derivatives can initiate or inhibit superoxide (O2 -) release in neutrophils. The mechanism by which one of these derivatives, farnesyl thiotriazole (FTT), initiates O2 - release in neutrophils is the subject of this paper. Treatment of guinea pig neutrophils with FTT results in the rapid release of O2 - by a route shown to be independent of the chemotactic peptide N-formyl-Met-Leu-Phe (fMLP) receptor. The signal transduction pathway utilized by the chemoattractant fMLP is generally accepted as the paradigm for receptor-mediated stimulation of O2 - production. Antagonists of fMLP had no effect on FTT-induced O2 - release, and pretreatment of neutrophils with fMLP had no effect on the ability of FTT to trigger further O2 - generation. In fact, FTT behaves like a ypical protein kinase C (PKC) activator. It promotes phosphorylation of the 47-kDa subunit of the NADH oxidase complex (p47-phox) in neutrophils, and this phosphorylation is specifically blocked by 1-(5-isoquinolinylsulfonyl)-2-methylpiperazine (H-7), an antagonist of PKC. FTT is also shown to activate PKC in vitro in a specific and saturable fashion. FTT is approximately equipotent with (S)-diolein, a physiologically relevant activator of this kinase. FTT represents a new, and quite novel, structure for a PKC activator. PKC activators include diglycerides and the structurally diverse tumor promoters.

Original languageEnglish
Pages (from-to)3916-3920
Number of pages5
JournalBiochemistry
Volume34
Issue number12
Publication statusPublished - 1995 Dec 1
Externally publishedYes

Fingerprint

Protein Kinase C
Neutrophils
methionyl-leucyl-phenylalanine
1-(5-Isoquinolinesulfonyl)-2-Methylpiperazine
Phosphorylation
Derivatives
Signal transduction
farnesylthiotriazole
Diglycerides
Chemotactic Factors
Superoxides
Carcinogens
Signal Transduction
Guinea Pigs
Phosphotransferases
Peptides

ASJC Scopus subject areas

  • Biochemistry

Cite this

Gilbert, B. A., Lim, Y. H., Ding, J., Badwey, J. A., & Rando, R. R. (1995). Farnesyl thiotriazole, a potent neutrophil agonist and structurally novel activator of protein kinase C. Biochemistry, 34(12), 3916-3920.

Farnesyl thiotriazole, a potent neutrophil agonist and structurally novel activator of protein kinase C. / Gilbert, Bryant A.; Lim, Young Hee; Ding, Jiabing; Badwey, John A.; Rando, Robert R.

In: Biochemistry, Vol. 34, No. 12, 01.12.1995, p. 3916-3920.

Research output: Contribution to journalArticle

Gilbert, BA, Lim, YH, Ding, J, Badwey, JA & Rando, RR 1995, 'Farnesyl thiotriazole, a potent neutrophil agonist and structurally novel activator of protein kinase C', Biochemistry, vol. 34, no. 12, pp. 3916-3920.
Gilbert, Bryant A. ; Lim, Young Hee ; Ding, Jiabing ; Badwey, John A. ; Rando, Robert R. / Farnesyl thiotriazole, a potent neutrophil agonist and structurally novel activator of protein kinase C. In: Biochemistry. 1995 ; Vol. 34, No. 12. pp. 3916-3920.
@article{e958000e2a1e4982a47479170c015030,
title = "Farnesyl thiotriazole, a potent neutrophil agonist and structurally novel activator of protein kinase C",
abstract = "Farnesylcysteine derivatives can initiate or inhibit superoxide (O2 -) release in neutrophils. The mechanism by which one of these derivatives, farnesyl thiotriazole (FTT), initiates O2 - release in neutrophils is the subject of this paper. Treatment of guinea pig neutrophils with FTT results in the rapid release of O2 - by a route shown to be independent of the chemotactic peptide N-formyl-Met-Leu-Phe (fMLP) receptor. The signal transduction pathway utilized by the chemoattractant fMLP is generally accepted as the paradigm for receptor-mediated stimulation of O2 - production. Antagonists of fMLP had no effect on FTT-induced O2 - release, and pretreatment of neutrophils with fMLP had no effect on the ability of FTT to trigger further O2 - generation. In fact, FTT behaves like a ypical protein kinase C (PKC) activator. It promotes phosphorylation of the 47-kDa subunit of the NADH oxidase complex (p47-phox) in neutrophils, and this phosphorylation is specifically blocked by 1-(5-isoquinolinylsulfonyl)-2-methylpiperazine (H-7), an antagonist of PKC. FTT is also shown to activate PKC in vitro in a specific and saturable fashion. FTT is approximately equipotent with (S)-diolein, a physiologically relevant activator of this kinase. FTT represents a new, and quite novel, structure for a PKC activator. PKC activators include diglycerides and the structurally diverse tumor promoters.",
author = "Gilbert, {Bryant A.} and Lim, {Young Hee} and Jiabing Ding and Badwey, {John A.} and Rando, {Robert R.}",
year = "1995",
month = "12",
day = "1",
language = "English",
volume = "34",
pages = "3916--3920",
journal = "Biochemistry",
issn = "0006-2960",
publisher = "American Chemical Society",
number = "12",

}

TY - JOUR

T1 - Farnesyl thiotriazole, a potent neutrophil agonist and structurally novel activator of protein kinase C

AU - Gilbert, Bryant A.

AU - Lim, Young Hee

AU - Ding, Jiabing

AU - Badwey, John A.

AU - Rando, Robert R.

PY - 1995/12/1

Y1 - 1995/12/1

N2 - Farnesylcysteine derivatives can initiate or inhibit superoxide (O2 -) release in neutrophils. The mechanism by which one of these derivatives, farnesyl thiotriazole (FTT), initiates O2 - release in neutrophils is the subject of this paper. Treatment of guinea pig neutrophils with FTT results in the rapid release of O2 - by a route shown to be independent of the chemotactic peptide N-formyl-Met-Leu-Phe (fMLP) receptor. The signal transduction pathway utilized by the chemoattractant fMLP is generally accepted as the paradigm for receptor-mediated stimulation of O2 - production. Antagonists of fMLP had no effect on FTT-induced O2 - release, and pretreatment of neutrophils with fMLP had no effect on the ability of FTT to trigger further O2 - generation. In fact, FTT behaves like a ypical protein kinase C (PKC) activator. It promotes phosphorylation of the 47-kDa subunit of the NADH oxidase complex (p47-phox) in neutrophils, and this phosphorylation is specifically blocked by 1-(5-isoquinolinylsulfonyl)-2-methylpiperazine (H-7), an antagonist of PKC. FTT is also shown to activate PKC in vitro in a specific and saturable fashion. FTT is approximately equipotent with (S)-diolein, a physiologically relevant activator of this kinase. FTT represents a new, and quite novel, structure for a PKC activator. PKC activators include diglycerides and the structurally diverse tumor promoters.

AB - Farnesylcysteine derivatives can initiate or inhibit superoxide (O2 -) release in neutrophils. The mechanism by which one of these derivatives, farnesyl thiotriazole (FTT), initiates O2 - release in neutrophils is the subject of this paper. Treatment of guinea pig neutrophils with FTT results in the rapid release of O2 - by a route shown to be independent of the chemotactic peptide N-formyl-Met-Leu-Phe (fMLP) receptor. The signal transduction pathway utilized by the chemoattractant fMLP is generally accepted as the paradigm for receptor-mediated stimulation of O2 - production. Antagonists of fMLP had no effect on FTT-induced O2 - release, and pretreatment of neutrophils with fMLP had no effect on the ability of FTT to trigger further O2 - generation. In fact, FTT behaves like a ypical protein kinase C (PKC) activator. It promotes phosphorylation of the 47-kDa subunit of the NADH oxidase complex (p47-phox) in neutrophils, and this phosphorylation is specifically blocked by 1-(5-isoquinolinylsulfonyl)-2-methylpiperazine (H-7), an antagonist of PKC. FTT is also shown to activate PKC in vitro in a specific and saturable fashion. FTT is approximately equipotent with (S)-diolein, a physiologically relevant activator of this kinase. FTT represents a new, and quite novel, structure for a PKC activator. PKC activators include diglycerides and the structurally diverse tumor promoters.

UR - http://www.scopus.com/inward/record.url?scp=0028903813&partnerID=8YFLogxK

UR - http://www.scopus.com/inward/citedby.url?scp=0028903813&partnerID=8YFLogxK

M3 - Article

VL - 34

SP - 3916

EP - 3920

JO - Biochemistry

JF - Biochemistry

SN - 0006-2960

IS - 12

ER -